(19)
(11) EP 0 660 824 A1

(12)

(43) Date of publication:
05.07.1995 Bulletin 1995/27

(21) Application number: 93922191.0

(22) Date of filing: 13.09.1993
(51) International Patent Classification (IPC): 
A61K 31/ 435( . )
A61P 35/ 00( . )
C07D 401/ 04( . )
A61K 31/ 473( . )
C07D 221/ 18( . )
C07D 401/ 06( . )
(86) International application number:
PCT/US1993/008640
(87) International publication number:
WO 1994/006771 (31.03.1994 Gazette 1994/08)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB IE IT LI NL SE

(30) Priority: 11.09.1992 US 19920943634

(71) Applicant: RESEARCH CORPORATION TECHNOLOGIES
Tucson, Arizona 85711-3335 (US)

(72) Inventors:
  • ALBERTS, David, S.
    Tucson, AZ 85711 (US)
  • DORR, Robert, T.
    Tucson, AZ 85718 (US)
  • REMERS, William, A.
    Tucson, AZ 85718 (US)
  • SAMI, Salah, M.
    Tucson, AZ 85719 (US)

(74) Representative: Hansen, Bernd, Dr. Dipl.-Chem., et al 
Hoffmann, Eitle & Partner, Patentanwälte, Arabellastrasse 4
D-81925 München
D-81925 München (DE)

   


(54) 1,2 DIHYDRO-3-H-DIBENZ(de,h) ISOQUINOLINE 1,3 DIONE AND THEIR USE AS ANTICANCER AGENTS